Menu
GeneBe

14-90184242-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_022054.4(KCNK13):c.466A>G(p.Ile156Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000549 in 1,614,220 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00057 ( 1 hom. )

Consequence

KCNK13
NM_022054.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.20
Variant links:
Genes affected
KCNK13 (HGNC:6275): (potassium two pore domain channel subfamily K member 13) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a potassium channel containing two pore-forming domains. This protein is an open channel that can be stimulated by arachidonic acid and inhibited by the anesthetic halothane. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.014981687).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
KCNK13NM_022054.4 linkuse as main transcriptc.466A>G p.Ile156Val missense_variant 2/2 ENST00000282146.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
KCNK13ENST00000282146.5 linkuse as main transcriptc.466A>G p.Ile156Val missense_variant 2/21 NM_022054.4 P1

Frequencies

GnomAD3 genomes
AF:
0.000335
AC:
51
AN:
152212
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000617
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000266
AC:
67
AN:
251432
Hom.:
0
AF XY:
0.000302
AC XY:
41
AN XY:
135888
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000519
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000571
AC:
835
AN:
1461890
Hom.:
1
Cov.:
32
AF XY:
0.000536
AC XY:
390
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000708
Gnomad4 OTH exome
AF:
0.000596
GnomAD4 genome
AF:
0.000335
AC:
51
AN:
152330
Hom.:
0
Cov.:
33
AF XY:
0.000255
AC XY:
19
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.0000962
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000617
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000542
Hom.:
0
Bravo
AF:
0.000314
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000247
AC:
30
EpiCase
AF:
0.000491
EpiControl
AF:
0.000711

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 06, 2021The c.466A>G (p.I156V) alteration is located in exon 2 (coding exon 2) of the KCNK13 gene. This alteration results from a A to G substitution at nucleotide position 466, causing the isoleucine (I) at amino acid position 156 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.74
Cadd
Benign
5.5
Dann
Benign
0.61
DEOGEN2
Benign
0.0034
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.77
T
M_CAP
Benign
0.0081
T
MetaRNN
Benign
0.015
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.81
L
MutationTaster
Benign
0.98
N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.32
N
REVEL
Benign
0.027
Sift
Benign
0.44
T
Sift4G
Benign
0.68
T
Polyphen
0.0030
B
Vest4
0.026
MVP
0.26
MPC
0.19
ClinPred
0.017
T
GERP RS
-2.9
Varity_R
0.025
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149601253; hg19: chr14-90650586; API